OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, et al.
Science Advances (2022) Vol. 8, Iss. 33
Open Access | Times Cited: 41
Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, et al.
Science Advances (2022) Vol. 8, Iss. 33
Open Access | Times Cited: 41
Showing 26-50 of 41 citing articles:
Global trends in research on endothelial cells and sepsis between 2002 and 2022: A systematic bibliometric analysis
Yue Shi, Shunpan Ji, Yuhai Xu, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23599-e23599
Open Access | Times Cited: 7
Yue Shi, Shunpan Ji, Yuhai Xu, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23599-e23599
Open Access | Times Cited: 7
Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics
Aniruddh Jhanwar, Dipika Sharma, Uddipan Das
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134850-134850
Closed Access | Times Cited: 1
Aniruddh Jhanwar, Dipika Sharma, Uddipan Das
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134850-134850
Closed Access | Times Cited: 1
Type 2 Diabetes Mellitus Aggravates Complement Dysregulation and Affects Cortisol Response in Patients with Post-COVID-19
Wenrui Ji, Xiaomin Xie, Guirong Bai, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 3849-3861
Open Access | Times Cited: 1
Wenrui Ji, Xiaomin Xie, Guirong Bai, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 3849-3861
Open Access | Times Cited: 1
Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐19
Ickjai Lee, Christopher Lupfer
Immunological Reviews (2024)
Closed Access | Times Cited: 1
Ickjai Lee, Christopher Lupfer
Immunological Reviews (2024)
Closed Access | Times Cited: 1
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme, et al.
The EMBO Journal (2024) Vol. 43, Iss. 7, pp. 1135-1163
Open Access | Times Cited: 1
Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme, et al.
The EMBO Journal (2024) Vol. 43, Iss. 7, pp. 1135-1163
Open Access | Times Cited: 1
Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde
Marco Mannes, Dimitrios C. Mastellos, Kristina Nilsson Ekdahl, et al.
Seminars in Immunology (2022) Vol. 60, pp. 101640-101640
Closed Access | Times Cited: 7
Marco Mannes, Dimitrios C. Mastellos, Kristina Nilsson Ekdahl, et al.
Seminars in Immunology (2022) Vol. 60, pp. 101640-101640
Closed Access | Times Cited: 7
Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies
Stefanos A. Tsiftsoglou
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5198-5214
Open Access | Times Cited: 3
Stefanos A. Tsiftsoglou
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5198-5214
Open Access | Times Cited: 3
Trichosanates A–G and cucurbitacins W–Y, anticomplement monoterpenoids and cucurbitane-type triterpenoids from the pericarps of Trichosanthes kirilowii
Shuiyuan Yang, Lin-Feng Guo, Yang Liu, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106710-106710
Closed Access | Times Cited: 2
Shuiyuan Yang, Lin-Feng Guo, Yang Liu, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106710-106710
Closed Access | Times Cited: 2
Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19
Daisuke Kasugai, Taku Tanaka, Takako Suzuki, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Daisuke Kasugai, Taku Tanaka, Takako Suzuki, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The future of complement therapeutics
Martin Kolev, Kollu N. Rao, Michael W. Yeh, et al.
Exploration of Immunology (2024), pp. 577-615
Open Access
Martin Kolev, Kollu N. Rao, Michael W. Yeh, et al.
Exploration of Immunology (2024), pp. 577-615
Open Access
A potential bimodal interplay between heme and complement factor H 402H in the deregulation of the complement alternative pathway by SARS-CoV-2
Stefanos A. Tsiftsoglou, Eleni Gavriilaki
Infection Genetics and Evolution (2024) Vol. 126, pp. 105698-105698
Open Access
Stefanos A. Tsiftsoglou, Eleni Gavriilaki
Infection Genetics and Evolution (2024) Vol. 126, pp. 105698-105698
Open Access
Recent developments in C3-targeted complement therapeutics
Dimitrios C. Mastellos, John D. Lambris
Seminars in Immunology (2022) Vol. 60, pp. 101645-101645
Closed Access | Times Cited: 3
Dimitrios C. Mastellos, John D. Lambris
Seminars in Immunology (2022) Vol. 60, pp. 101645-101645
Closed Access | Times Cited: 3
How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system
Bo Nilsson, Oskar Eriksson, Karin Fromell, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 1
Bo Nilsson, Oskar Eriksson, Karin Fromell, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 1
C3 targeted complement therapy for chronic periodontitis – A scoping review
Rupali Agnihotri, Sumit Gaur
Journal of International Society of Preventive and Community Dentistry (2022) Vol. 12, Iss. 5, pp. 500-505
Open Access | Times Cited: 1
Rupali Agnihotri, Sumit Gaur
Journal of International Society of Preventive and Community Dentistry (2022) Vol. 12, Iss. 5, pp. 500-505
Open Access | Times Cited: 1
Editorial: The impact of COVID-19 on immune system-related complications in surgical patients
Philip F. Stahel, Sebastian Weckbach, Markus Huber‐Lang, et al.
Frontiers in Surgery (2023) Vol. 10
Open Access
Philip F. Stahel, Sebastian Weckbach, Markus Huber‐Lang, et al.
Frontiers in Surgery (2023) Vol. 10
Open Access
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Karel Van Damme, Levi Hoste, Jozefien Declercq, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Karel Van Damme, Levi Hoste, Jozefien Declercq, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2
Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
